X0508 4 2024-06-13 0001404281 Eledon Pharmaceuticals, Inc. ELDN 0001749385 Little Paul Sean C/O ELEDON PHARMACEUTICALS, INC. 19800 MACARTHUR BLVD STE. 250 IRVINE CA 92612 false true false false Chief Financial Officer false Stock Option (right to buy) 2.30 2024-06-13 4 A false 267470 0 A 2033-05-01 Common Stock 267470 267470 D This transaction represents the attainment of the performance conditions applicable to an option award subject to both performance-based and time-based vesting criteria granted to the reporting person on May 1, 2023. The option was determined to satisfy the performance-based vesting criteria with respect to 267,470 shares of underlying Common Stock on June 13, 2024 and time-based vesting criteria with respect to 66,867 shares of underlying Common Stock on May 1, 2024. The option will satisfy the time-based vesting criteria with respect to the 200,603 remaining shares of Common Stock underlying the option in substantially equal quarterly installments over a three-year period ending May 1, 2027. /s/ Paul Little. 2024-06-14